Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 3 de 3
1.
Ital Heart J ; 5(4): 299-301, 2004 Apr.
Article En | MEDLINE | ID: mdl-15185890

Cardiac hemangiomas are exceptionally rare tumors with an incidence of 1 to 3% of all detected benign heart neoplasms. We report 2 cases of left atrial hemangioma of which only one associated with clinical symptoms such as dyspnea and palpitations. Two years following surgical excision of the tumors, there was no echocardiographic evidence of recurrence.


Heart Neoplasms/diagnostic imaging , Heart Neoplasms/pathology , Hemangioma/diagnostic imaging , Hemangioma/pathology , Aged , Female , Heart Atria/diagnostic imaging , Heart Atria/pathology , Heart Atria/surgery , Heart Neoplasms/surgery , Hemangioma/surgery , Humans , Male , Ultrasonography
2.
Ital Heart J Suppl ; 5(2): 154-9, 2004 Feb.
Article It | MEDLINE | ID: mdl-15080536

A clinical case of non-obstructive hypertrophic cardiomyopathy with involvement of the right ventricle is reported. The patient was a 42-year-old male with symptoms suggesting an effort angina of recent onset. The diagnosis was established by echocardiography, which showed asymmetric hypertrophy of the interventricular septum (20 mm), hypertrophy of the right ventricular free wall, and severe hypertrophy of the septal papillary muscle of the tricuspid valve. The patient underwent a complete diagnostic evaluation, including exercise stress test, Holter monitoring, magnetic resonance, myocardial tomoscintigraphy and complete hemodynamic assessment. Medical treatment with atenolol 50 mg day was started; at 1-year follow-up the patient's clinical conditions are good, with decrease of anginal episodes. The literature review elicits the paucity of information about this condition, despite a frequent involvement of both ventricles in hypertrophic obstructive cardiomyopathy. The case reported shows two atypical aspects: a) the involvement of the right ventricle in non-obstructive hypertrophic cardiomyopathy is anecdotal; b) this pattern of hypertrophy (right ventricular free wall/septal papillary muscle) has never been previously reported. Right ventricular involvement in patients with hypertrophic cardiomyopathy must be carefully investigated, because it may be more frequent than conventionally deemed.


Cardiomyopathy, Hypertrophic/pathology , Hypertrophy, Right Ventricular/pathology , Adrenergic beta-Antagonists/therapeutic use , Adult , Angina Pectoris/etiology , Atenolol/therapeutic use , Cardiomyopathy, Hypertrophic/complications , Cardiomyopathy, Hypertrophic/diagnostic imaging , Cardiomyopathy, Hypertrophic/drug therapy , Cardiomyopathy, Hypertrophic/epidemiology , Echocardiography , Electrocardiography, Ambulatory , Exercise Test , Heart Septum/diagnostic imaging , Heart Septum/pathology , Hemodynamics , Humans , Hypertrophy, Right Ventricular/complications , Hypertrophy, Right Ventricular/diagnostic imaging , Hypertrophy, Right Ventricular/drug therapy , Male , Physical Exertion , Prevalence , Tricuspid Valve/diagnostic imaging , Tricuspid Valve/pathology
3.
Ital Heart J Suppl ; 3(6): 607-12, 2002 Jun.
Article It | MEDLINE | ID: mdl-12116809

BACKGROUND: We evaluated the appropriateness of the prescription of echocardiography, exercise testing, Holter monitoring and vascular sonography for ambulatory patients, performed during 4 weeks in 21 outpatient laboratories in Tuscany and Umbria, Italy. METHODS: We collected the following data: the appropriateness of the prescription (according to the guidelines of the Italian Federation of Cardiology), the prescribing physician (cardiologist vs noncardiologist), the synthetic result (normal vs abnormal) and the clinical utility (useful vs useless) of each exam. RESULTS: We evaluated 5614 prescriptions (patients: 3027 males, 2587 females; mean age 63 years, range 14-96 years). The indication to the test was of class I (appropriate) in 45.3%, of class II (doubtfully appropriate) in 34.8% and of class III (inappropriate) in 19.9% of the cases. The test was abnormal in 58.3% of class I exams vs 17% of class III exams (p < 0.05). The test was useful in 72.4% of class I exams vs 17.1% of class III exams (p < 0.05). The test was prescribed by a cardiologist in 1882 cases (33.5%). Cardiologist-prescribed exams were of class I in 57.3%, of class II in 32.4% and of class III in 10.3% of the cases vs 39.2, 36.1 and 24.7% of non-cardiologist-prescribed exams (p < 0.05). Cardiologist-prescribed exams were abnormal in 53.4% of the cases vs 39% of those of non-cardiologists' (odds ratio 1.76, 95% confidence interval 1.58-1.97; p < 0.05). Cardiologist-prescribed exams were useful in 64.7% of the cases vs 44.4% of those of non-cardiologists' (odds ratio 2.26, 95% confidence interval 2.02-2.53; p < 0.05). CONCLUSIONS: In Tuscany and Umbria, Italy, less than half of the prescriptions for non-invasive diagnostic tests are appropriate: appropriately prescribed exams more often provide abnormal and useful results; cardiologist-prescribed exams are more often appropriate, abnormal and useful.


Cardiology/standards , Diagnostic Techniques, Cardiovascular/statistics & numerical data , Diagnostic Techniques, Cardiovascular/standards , Practice Patterns, Physicians'/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , Ambulatory Care/standards , Cardiology/statistics & numerical data , Echocardiography/standards , Echocardiography/statistics & numerical data , Electrocardiography, Ambulatory/standards , Electrocardiography, Ambulatory/statistics & numerical data , Evaluation Studies as Topic , Exercise Test/standards , Exercise Test/statistics & numerical data , Female , Humans , Italy , Male , Medicine/standards , Medicine/statistics & numerical data , Middle Aged , Odds Ratio , Predictive Value of Tests , Specialization , Utilization Review
...